Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-25

Clinical Trial Update: Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial investigating orthostatic dysregulation and related GI dysfunction in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Christian Baumann | Conditions: Autonomic Disturbances in Parkinson's Disease | Phase 2 | Status: COMPLETED